CLN.SW Stock Analysis
CL
Avoid
Based on Eyestock quantitative analysis, CLN.SW`s fundamental data and valuation indicate an investment grade of Avoid at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Overvalued
Clariant AG engages in the development, manufacture, distribution, and sale of specialty chemicals. The company is headquartered in Muttenz, Basel-Landschaft and currently employs 11,148 full-time employees. The company went IPO on 2001-05-21. The company operates through three business areas: Care Chemicals, Catalysis, Natural Resources. The Business Area Care Chemicals serves customers in the personal care, home care, paints and coatings, and crop solutions markets. Business Area Catalysis offers catalytic and biofuel solutions. The Business Area Natural Resources offers products and customer-tailored solutions for mineral, foundry, oil, and gas extraction businesses, as well as for food, plastics, coatings, adhesives, and inks applications.